U.S. Markets open in 8 hrs 42 mins
  • Gold

    1,787.50
    +5.60 (+0.31%)
     
  • EUR/USD

    1.1631
    0.0000 (-0.0000%)
     
  • 10-Yr Bond

    1.6760
    -1.6760 (-100.00%)
     
  • Vix

    15.01
    -15.49 (-100.00%)
     
  • GBP/USD

    1.3796
    +0.0001 (+0.0055%)
     
  • USD/JPY

    114.0160
    +0.0280 (+0.0246%)
     
  • BTC-USD

    62,906.06
    -2,149.50 (-3.30%)
     
  • CMC Crypto 200

    1,497.27
    -37.38 (-2.44%)
     
  • FTSE 100

    7,190.30
    -32.80 (-0.45%)
     
  • Nikkei 225

    28,839.60
    +131.02 (+0.46%)
     

LAWSUITS FILED AGAINST AHCO, PHG and ANVS - Jakubowitz Law Pursues Shareholders Claims

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, NY / ACCESSWIRE / September 10, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.

AdaptHealth Corp. f/k/a DFB Healthcare Acquisitions Corp. (NASDAQ:AHCO)

CONTACT JAKUBOWITZ ABOUT AHCO:
https://claimyourloss.com/securities/adapthealth-corp-f-k-a-dfb-healthcare-acquisitions-corp-loss-submission-form/?id=19478&from=1

Class Period: November 11, 2019 - July 16, 2021

Lead Plaintiff Deadline: September 27, 2021

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) AdaptHealth had misrepresented its organic growth trajectory by retroactively inflating past organic growth numbers without disclosing the changes, in violation of Securities and Exchange Commission regulations; (ii) accordingly, the Company had materially overstated its financial prospects; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

Koninklijke Philips N.V. (NYSE:PHG)

CONTACT JAKUBOWITZ ABOUT PHG:
https://claimyourloss.com/securities/koninklijke-philips-n-v-loss-submission-form/?id=19478&from=1

Class Period: February 25, 2020 - June 11, 2021

Lead Plaintiff Deadline: October 15, 2021

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Philips had deficient product manufacturing controls or procedures; (ii) as a result, the Company's Bi-Level PAP and CPAP devices and mechanical ventilators were manufactured using hazardous materials; (iii) accordingly, the Company's sales revenues from the foregoing products were unsustainable; (iv) the foregoing also subjected the Company to a substantial risk of a product recall, in addition to potential legal and/or regulatory action; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.

Annovis Bio, Inc. (NYSE:ANVS)

CONTACT JAKUBOWITZ ABOUT ANVS:
https://claimyourloss.com/securities/annovis-bio-inc-loss-submission-form/?id=19478&from=1

Class Period: May 21, 2021 - July 28, 2021

Lead Plaintiff Deadline: October 18, 2021

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Annovis's ANVS401 (Posiphen), an orally administrated drug which purportedly inhibited the synthesis of neurotoxic proteins that are the main cause of neurodegeneration, did not show statistically significant results across two patient populations as to factors such as orientation, judgement, and problem solving; and (2) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887

SOURCE: Jakubowitz Law



View source version on accesswire.com:
https://www.accesswire.com/663517/LAWSUITS-FILED-AGAINST-AHCO-PHG-and-ANVS--Jakubowitz-Law-Pursues-Shareholders-Claims